{"id":31257,"date":"2016-06-03T18:31:41","date_gmt":"2016-06-03T18:31:41","guid":{"rendered":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/root\/iv-interna\/vyskum\/projekty\/"},"modified":"2022-11-13T22:07:19","modified_gmt":"2022-11-13T21:07:19","slug":"projekty","status":"publish","type":"cpt_klinika","link":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/iv-interna\/vyskum\/projekty\/","title":{"rendered":"Grantov\u00e9 projekty rie\u0161en\u00e9 od r. 2007"},"content":{"rendered":"
VEGA 1\/4304\/07 2007-2009<\/strong>. Sledovanie efektu polymorfizmov kandid\u00e1tskych g\u00e9nov na vek manifest\u00e1cie diabetes mellitus 2. typu, hladiny rizikov\u00fdch faktorov ateroskler\u00f3zy a\u00a0v\u00fdskyt makrovaskul\u00e1rnych komplik\u00e1ci\u00ed diabetu.
\nVed\u00faci projektu \u2013 prof. MUDr. I. Tk\u00e1\u010d, PhD.
\n\u00daspe\u0161n\u00e9 ukon\u010denie projektu.
\n\u00a0
\nVEGA 1\/0380\/10 2010-2011<\/strong>. Sledovanie vplyvu polymorfizmov kandid\u00e1tskych g\u00e9nov diabetes mellitus 2. typu na efekt lie\u010dby or\u00e1lnymi antidiabetikami zo skup\u00edn deriv\u00e1tov sufonylurey a\u00a0inhib\u00edtorov dipeptidylpeptid\u00e1zy 4.
\nVed\u00faci projektu \u2013 prof. MUDr. I. Tk\u00e1\u010d, PhD., z\u00e1stupca ved\u00faceho projektu \u2013 MUDr. M. Javorsk\u00fd, PhD.
\n\u00daspe\u0161n\u00e9 ukon\u010denie projektu a\u00a0dosiahnutie vynikaj\u00facich v\u00fdsledkov.
\n\u00a0
\nVEGA 1\/0112\/11 2011-2013<\/strong>. Sledovanie vz\u0165ahu polymorfizmov niektor\u00fdch kandid\u00e1tskych g\u00e9nov ateroskler\u00f3zy k angiograficky diagnostikovanej z\u00e1va\u017enosti koron\u00e1rnej choroby srdca u diabetikov a u pacientov bez diabetu.
\nVed\u00faci projektu \u2013 MUDr. M. Javorsk\u00fd, PhD., z\u00e1st. ved. projektu \u2013 prof. MUDr. I. Tk\u00e1\u010d, PhD.
\n\u00daspe\u0161n\u00e9 ukon\u010denie projektu a\u00a0dosiahnutie vynikaj\u00facich v\u00fdsledkov.
\n\u00a0
\nVEGA 1\/0340\/12 2012-2014<\/strong>. Sledovanie efektu polymorfizmov g\u00e9nov ovplyv\u0148uj\u00facich farmakokinetiku a\u00a0farmakodynamiku metform\u00ednu na \u00fa\u010dinok lie\u010dby metform\u00ednom u\u00a0pacientov s\u00a0diabetom 2. typu.
\nVed\u00faci projektu \u2013 prof. MUDr. I. Tk\u00e1\u010d, PhD., z\u00e1st. ved. projektu \u2013 MUDr. M. Javorsk\u00fd, PhD.
\n\u00daspe\u0161n\u00e9 ukon\u010denie projektu a\u00a0dosiahnutie vynikaj\u00facich v\u00fdsledkov.
\n\u00a0
\nAPVV-0134\/11 2012-2015<\/strong>. \u00daloha hypoxie v\u00a0aktiv\u00e1cii molekul\u00e1rnych dr\u00e1h asociovan\u00fdch so zv\u00fd\u0161en\u00fdm kardiovaskul\u00e1rnym rizikom u\u00a0pacientov so sp\u00e1nkov\u00fdm apnoe a\u00a0ich ovplyvnenie lie\u010dbou.
\nZodpovedn\u00e1 rie\u0161ite\u013eka \u2013 prof. MUDr. R. Tk\u00e1\u010dov\u00e1, DrSc., ved\u00faci pracovn\u00e9ho bal\u00edka 1 \u2013 prof. MUDr. I. Tk\u00e1\u010d, PhD.
\n\u00a0
\nVEGA 1\/0389\/14 2014-2016<\/strong>. Sledovanie vz\u0165ahu variantov vybran\u00fdch kandid\u00e1tskych g\u00e9nov ateroskler\u00f3zy na z\u00e1va\u017enos\u0165 perif\u00e9rneho art\u00e9riov\u00e9ho obliteruj\u00faceho ochorenia doln\u00fdch kon\u010dat\u00edn u diabetikov 2. typu.
\nVed\u00faca projektu \u2013 MUDr. Miriam Koz\u00e1rov\u00e1, PhD., z\u00e1stupca ved. projektu \u2013 prof. MUDr. Ivan Tk\u00e1\u010d, PhD.
\n\u00a0
\nVEGA 1\/0027\/16 2016-2019<\/strong>. Sledovanie asoci\u00e1ci\u00ed vybran\u00fdch g\u00e9nov\u00fdch variantov s odpove\u010fou na lie\u010dbu or\u00e1lnymi antidiabetikami glipt\u00ednmi.
\nVed\u00faci projektu \u2013 prof. MUDr. Ivan Tk\u00e1\u010d, PhD., z\u00e1st. ved. projektu \u2013 MUDr. Martin Javorsk\u00fd, PhD.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":31253,"menu_order":0,"template":"","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[],"tags":[],"tax_aktuality":[],"class_list":["post-31257","cpt_klinika","type-cpt_klinika","status-publish","hentry"],"acf":{"acf_link_na_externy_obsah":""},"yoast_head":"\n